Список литературы

    1. Бойко Э. В. Опыт лечения пациентов с меланомой хориоидеи с помощью радиохирургической установки «Гамма-нож» / Э.В. Бойко, К.С. Жоголев, П.И. Иванов, И.С. Зубаткина // Современные технологии в офтальмологии. – 2016. – №. 1. – С. 40.

    2. Бойко Э. В., Шишкин М. М., Ян А. В. Транссклеральная термотерапия в лечении меланомы сосудистой оболочки //Опухоли и опухолеподобные заболевания органа зрения: Сб. науч. трудов.–М. – 2007. – С. 31-35.

    3. Бровкина А. Ф. (ред.). Офтальмоонкология: руководство для врачей. – Медицина, 2002.

    4. Гришина Е. Е., Федотова О. Ф., Житенев В. П. Анализ офтальмоонкологической патологии у взрослого населения Москвы по данным МОКБ //Опухоли и опухолеподобные заболевания органа зрения. М. – 1998. – С. 23-24.

    5. Долгушин Б. И. и др. Трансартериальная химиоэмболизация при метастазах увеальной меланомы в печени //Вестник рентгенологии и радиологии. – 2016. – Т. 97. – №. 4. – С. 215-223.

    6. Жабина А. С. и др. Частота экспрессии предсказательных маркеров к цитостатикам у пациентов с меланомой кожи //Вопр онкол. – 2010. – Т. 56. – №. 6. – С. 677-80.

    7. Жильцова М. Г. Тонкоигольная аспирационная биопсия в диагностике опухолей органа зрения : дис. – Московский научно-исследовательский онкологический институт им. ПА Герцена, 2002.

    8. Кардава Т. Р. Многокомпонентное органосохранное лечение «больших» меланом хориоидеи : дис. – ТР Кардава.–Челябинск, 2008.-22 с, 2008.

    9. Кириличев А. И., Дегтярева С. В. Заболеваемость внутриглазными меланомами в регионе обслуживания Оренбургского межобластного офтальмоонкологического центра/АИ Кирилличев, СВ Дягтерева, ТФ Макарова //Опухоли и опухолеподобные заболевания органа зрения: тезисы науч.-практ. конф. с междунар. участием. – 1998. – С. 57-59.

    10. Либман Е. С. и др. К проблеме оценки качества жизни лиц со злокачественными новообразованиями органа зрения //Достижения и перспективы офтальмоонкологии: Сборник трудов юбилейной науч.-практ. конф. – 2001. – С. 13-15.

    11. Назарова В. В. и др. Современные тенденции в терапии увеальной меланомы: обзор проблемы //Злокачественные опухоли. – 2014. – №. 4 (11).

    12. Назарова В. В. и др. Перспективы иммунотерапии метастатической увеальной меланомы //Эффективная фармакотерапия. – 2016. – №. 39. – С. 68-73.

    13. Новик А. В. и др. Современные методы системного лечения метастатической меланомы //Вопросы онкологии. – 2015. – Т. 61. – №. 2. – С. 297-302.

    14. Проценко С. А. и др. Современные возможности персонализированной терапии метастатической меланомы //Современная онкология. – 2014. – Т. 16. – №. 3. – С. 57-64.

    15. Проценко С. А. Меланома кожи: новое в лекарственном лечении //Природа. – 2018. – №. 6. – С. 26-28.

    16. Ронкина Т. И., Линник Л. Ф., Заробелова О. Н. Диагностические возможности трансвитреальной тонкоигольчатой аспирационной биопсии внутриглазных новообразований //Новое в офтальмологии. – 1991. – Т. 2. – С. 49-56.

    17. Саакян С. В., Амирян А. Г., Миронова И. С. Анализ показателей качества жизни больных увеальной меланомой в отдаленном периоде в зависимости от возраста и вида лечения //Российский офтальмологический журнал. – 2016. – Т. 9. – №. 1. – С. 56-61.

    18. Хиониди Я. Н. Поздние осложнения брахитерапии увеальных меланом и меры их профилактики : дис. – Рос. мед. акад. последиплом. образования МЗ РФ, 2013.

    19. Цыганков А. Ю. Прогностическая значимость диагностики молекулярно-генетических изменений и их корреляция с клинико-морфологическими характеристиками при увеальной меланоме : дис. – Московский научно-исследовательский институт глазных болезней им. Гельмгольца, 2015.

    20. Чесалин И. П. Оценка эффективности брахитерапии больших меланом хориоидеи : дис. – Рос. мед. акад. последиплом. образования МЗ РФ, 2016.

    21. Ширина Т. В. Витальный прогноз при увеальной меланоме в отдаленные сроки после лечения. – 2013.

    22. Шишкин М. М., Резникова А. Б., Гусаревич О. Г. Отдаленные результаты и качество жизни после комбинированной хирургии больших меланом хориодеи //Российский общенациональный офтальмологический форум– 2009: Сб. науч. статей/ФГУ «МНИИ глазных болезней им. Гельмгольца».–М. – 2009. – Т. 2. – С. 90.

    23. Шишкин М. М. , Резникова А.Б. Отдаленные результаты комбинированной эндорезекции больших меланом хориоидеи // Сб.тезисов научно-практической конференции «Современные технологии лечения витреоретинальной патологии». М. - 2012. - С. 204-206.

    24. Яровой А. А. Органосохраняющее и функционально-сберегающее лечение меланомы хориоидеи на основе брахитерапии с рутением-106 и лазерной транспупиллярной термотерапии : дис. – ГУ" Межотраслевой НТК" Микрохирургия глаза"", 2010.

    25. Яровой А. А. и др. 12-летний опыт использования органосохраняющего лечения меланомы хориоидеи на основе брахитерапии с Ru-106+ Rh-106 и лазерной транспупиллярной термотерапии //Практическая медицина. – 2012. – Т. 2. – №. 4 (59).

    26. Яровой А. А., Горшков И. М., Голубева О. В. Эндовитреальное удаление увеальной меланомы: пятилетний опыт //Эффективная фармакотерапия. – 2016. – №. 39. – С. 64-67.

    27. Aaberg T. M. et al. Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma //British journal of ophthalmology. – 2008. – Vol. 92. – №. 6. – P. 741-746.

    28. Aalto Y. et al. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma //Investigative ophthalmology & visual science. – 2001. – Vol. 42. – №. 2. – P. 313-317.

    29. Abdel-Rahman M. H. et al. Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma //Modern Pathology. – 2011. – Vol. 24. – №. 7. – P. 954-962.

    30. Abi-Ayad N. et al. Transretinal uveal melanoma biopsy with 25-gauge vitrectomy system //Acta ophthalmologica. – 2013. – Vol. 91. – №. 3. – P. 279-281.

    31. Akgul H. et al. Intraocular biopsy using special forceps: a new instrument and refined surgical technique //British Journal of Ophthalmology. – 2011. – Vol. 95. – №. 1. – P. 79-82.

    32. Ali Z., Yousaf N., Larkin J. Melanoma epidemiology, biology and prognosis //EJC supplements. – 2013. – Vol. 11. – №. 2. – P. 81.

    33. Amaro A. et al. The biology of uveal melanoma //Cancer and Metastasis Reviews. – 2017. – Vol. 36. – №. 1. – P. 109-140.

    34. Andreoli M. T., Mieler W. F., Leiderman Y. I. Epidemiological trends in uveal melanoma //British Journal of Ophthalmology. – 2015. – Vol. 99. – №. 11. – P. 1550-1553.

    35. Angi M. et al. Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach //British Journal of Ophthalmology. – 2017. – Vol. 101. – №. 8. – P. 1143-1146.

    36. Augsburger J. J. et al. Fine needle aspiration biopsy in the diagnosis of intraocular cancer: cytologic-histologic correlations //Ophthalmology. – 1985. – 164 Vol. 92. – №. 1. – P. 39-49.

    37. Augsburger J. J. et al. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category //Transactions of the American Ophthalmological Society. – 2002. – Vol. 100. – P. 225.

    38. Augsburger J. J., Shields J. A. Fine needle aspiration biopsy of solid intraocular tumors: indications, instrumentation and techniques //Ophthalmic surgery. – 1984. – Vol. 15. – №. 1. – P. 34-40.

    39. Bagger M., Tebering J. F., Kiilgaard J. F. The ocular consequences and applicability of minimally invasive 25-gauge transvitreal retinochoroidal biopsy //Ophthalmology. – 2013. – Vol. 120. – №. 12. – P. 2565-2572.

    40. Baily C. et al. Uveal melanoma in Ireland //Ocular oncology and pathology. – 2019. – Vol. 5. – №. 3. – P. 195-204.

    41. Bakhoum M. F., Esmaeli B. Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project //Cancers. – 2019. – Vol. 11. – №. 8. – P. 1061.

    42. Balch C. M. et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system //Journal of clinical oncology. – 2001. – Vol. 19. – №. 16. – P. 3622-3634.

    43. Bataille V. et al. Risk of ocular melanoma in relation to cutaneous and iris naevi //International journal of cancer. – 1995. – Vol. 60. – №. 5. – P. 622-626.

    44. Bauer J. et al. Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma //British journal of cancer. – 2009. – Vol. 101. – №. 5. – P. 813-815.

    45. Bechrakis N. E., Foerster M. H., Bornfeld N. Biopsy in indeterminate intraocular tumors //Ophthalmology. – 2002. – Vol. 109. – №. 2. – P. 235-242.

    46. Bedford M. A. The use and abuse of cobalt plaques in the treatment of choroidal malignant melanomata //Transactions of the ophthalmological societies of the United Kingdom. – 1973. – Vol. 93. – P. 139-143.

    47. Van Beek J. G. M. et al. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients //Acta ophthalmologica. – 2018. – Vol. 96. – №. 8. – P. 841-848.

    48. Van Beek J. G. M. et al. Metastatic disease in uveal melanoma: importance of a genetic profile? //Melanoma research. – 2015. – Vol. 25. – №. 5. – P. 447-449.

    49. Beran T. M. et al. Reactions to and desire for prognostic testing in choroidal melanoma patients //Journal of genetic counseling. – 2009. – Vol. 18. – №. 3. – P. 265-274.

    50. Berus T. et al. Clinical, histopathological and cytogenetic prognosticators in uveal melanoma–A comprehensive review //Anticancer Research. – 2017. – Vol. 37. – №. 12. – P. 6541-6549.

    51. Biscotti C. V., Singh A. D. Uveal metastases //FNA Cytology of Ophthalmic Tumors. – Karger Publishers, 2012. – Vol. 21. – P. 17-30.

    52. Blanco-Rivera C., Capeáns-Tomé C., Otero-Cepeda X. L. Calidad de vida en pacientes con melanoma de coroides //Archivos de la Sociedad Espanola de Oftalmologia. – 2008. – Vol. 83. – №. 5. – P. 301-306.

    53. Bonaldi L. et al. FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas //Journal of cancer research and clinical oncology. – 2008. – Vol. 134. – №. 10. – P. 1123-1127.

    54. Bornfeld N. et al. Prognostic implications of monosomy 3 in uveal melanoma //The Lancet. – 1996. – Vol. 347. – №. 9010. – С. 1222-1225.

    55. Van den Bosch T. et al. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis //Investigative ophthalmology & visual science. – 2012. – Vol. 53. – №. 6. – P. 2668-2674.

    56. Brewington B. Y. et al. Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions //Clinical Ophthalmology (Auckland, NZ). – 2018. – Vol. 12. – P. 925.

    57. Brouwer N. J. et al. Tumour angiogenesis in uveal melanoma is related to genetic evolution //Cancers. – 2019. – Vol. 11. – №. 7. – P. 979.

    58. Carvajal R. D. et al. Metastatic disease from uveal melanoma: treatment options and future prospects //British Journal of Ophthalmology. – 2017. – Vol. 101. – №. 1. – P. 38-44.

    59. Chang A. E., Karnell L. H., Menck H. R. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade //Cancer: Interdisciplinary International Journal of the American Cancer Society. – 1998. – Vol. 83. – №. 8. – P. 1664-1678.

    60. Char D. H. et al. Iris ring melanoma: fine needle biopsy //British journal of ophthalmology. – 2006. – Vol. 90. – №. 4. – P. 420-422.

    61. Cohen V. M. L. et al. Transvitreal fine needle aspiration biopsy: the influence of intraocular lesion size on diagnostic biopsy result //Eye. – 2001. – Vol. 15. – №. 2. – P. 143-147.

    62. Cohen V. M. L. et al. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation //Acta Ophthalmologica Scandinavica. – 2003. – Vol. 81. – №. 4. – P. 383-388.

    63. Corrêa Z. M. Assessing prognosis in uveal melanoma //Cancer Control. – 2016. – Vol. 23. – №. 2. – P. 93-98.

    64. Correa Z. M., Augsburger J. J. Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications //Graefe's Archive for Clinical and Experimental Ophthalmology. – 2014. – Vol. 252. – №. 1. – P. 131-135.

    65. Coupland S. E., Campbell I., Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability //Ophthalmology. – 2008. – Vol. 115. – №. 10. – P. 1778-1785.

    66. De Cruz Jr P. O. L., Specht C. S., McLean I. W. Lymphocytic infiltration in uveal malignant melanoma //Cancer. – 1990. – Vol. 65. – №. 1. – P. 112-115.

    67. Damato B. et al. Endoresection of choroidal melanoma //British Journal of Ophthalmology. – 1998. – Vol. 82. – №. 3. – P. 213-218.

    68. Damato B. The role of eyewall resection in uveal melanoma management //International ophthalmology clinics. – 2006. – Vol. 46. – №. 1. – P. 81-93.

    69. Damato B. et al. Cytogenetics of uveal melanoma: a 7-year clinical experience //Ophthalmology. – 2007. – Vol. 114. – №. 10. – P. 1925-1931. e1.

    70. Damato B. Choroidal melanoma endoresection, dandelions and allegory-based medicine //British Journal of Ophthalmology. – 2008. – Vol. 92. – №. 8. – P. 1013-1014.

    71. Damato B. et al. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death //Investigative ophthalmology & visual science. – 2009. – Vol. 50. – №. 7. – P. 3048-3055.

    72. Damato B. et al. Intrascleral recurrence of uveal melanoma after transretinal “endoresection” //British Journal of Ophthalmology. – 2001. – Vol. 85. – №. 1. – P. 110-110.

    73. Damato B., Dopierala J. A., Coupland S. E. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification //Clinical cancer research. – 2010. – Vol. 16. – №. 24. – P. 6083-6092.

    74. Damato B. E. et al. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival //JAMA ophthalmology. – 2014. – Vol. 132. – №. 5. – P. 605-613.

    75. Daniels A. B. et al. High throughput mass spectrometry-based mutation profiling of primary uveal melanoma //Investigative ophthalmology & visual science. – 2012. – Vol. 53. – №. 11. – P. 6991-6996.

    76. Decatur C. L. et al. Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes //JAMA ophthalmology. – 2016. – Vol. 134. – №. 7. – P. 728-733.

    77. D Demirci H., Shields C. L., Shields J. A. New ophthalmic manifestations of branchio-oculo-facial syndrome //American journal of ophthalmology. – 2005. – Vol. 139. – №. 2. – P. 362-364.

    78. DeParis S. W. et al. External validation of the Liverpool uveal melanoma prognosticator online //Investigative ophthalmology & visual science. – 2016. – Vol. 57. – №. 14. – P. 6116-6122.

    79. Dinca E. B. et al. Survival and complications following Gamma Knife radiosurgery or enucleation for ocular melanoma: a 20-year experience //Acta neurochirurgica. – 2012. – Vol. 154. – №. 4. – P. 605-610.

    80. Dogrusöz M. et al. The prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status //Investigative ophthalmology & visual science. – 2017. – Vol. 58. – №. 2. – P. 833-842.

    81. Dogrusöz M., Jager M. J. Genetic prognostication in uveal melanoma //Acta Ophthalmologica. – 2018. – Vol. 96. – №. 4. – P. 331-347.

    82. Dono M. et al. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma //British journal of cancer. – 2014. – Vol. 110. – №. 4. – P. 1058-1065.

    83. Eagle R. C. The pathology of ocular cancer //Eye. – 2013. – Т. 27. – №. 2. – P. 128-136.

    84. Egan K. M. et al. Epidemiologic aspects of uveal melanoma //Survey of ophthalmology. – 1988. – Vol. 32. – №. 4. – P. 239-251.

    85. Egan K. M. et al. The Risk of Enucieatlon after Proton Beam Irradiation of Uveal Melanoma //Ophthalmology. – 1989. – Vol. 96. – №. 9. – P. 1377-1383.

    86. Ehlers J. P. et al. Integrative genomic analysis of aneuploidy in uveal melanoma //Clinical Cancer Research. – 2008. – Vol. 14. – №. 1. – P. 115-122.

    87. Eide N., Walaas L. Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review //Acta ophthalmologica. – 2009. – Vol. 87. – №. 6. – P. 588-601.

    88. Eleuteri A. et al. Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis //International Journal of Biomedical Engineering and Technology. – 2012. – Vol. 8. – №. 1. – P. 18-35.

    89. Essen T. H. van et al. Prognostic parameters in uveal melanoma and their association with BAP1 expression //British Journal of Ophthalmology. – 2014. – Vol. 98. – №. 12. – P. 1738-1743.

    90. Ewens K. G. et al. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome //Investigative ophthalmology & visual science. – 2013. – Vol. 54. – №. 8. – P. 5721-5729.

    91. Ewens K. G. et al. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma //Investigative ophthalmology & visual science. – 2014. – Vol. 55. – №. 8. – P. 5160-5167.

    92. Fernandes B. F., Marshall J. C. A., Burnier M. N. Blue light exposure and uveal melanoma //Ophthalmology. – 2006. – Vol. 113. – №. 6. – P. 1062-1062. e1.

    93. Field M. G. et al. PRAME as an independent biomarker for metastasis in uveal melanoma //Clinical cancer research. – 2016. – Vol. 22. – №. 5. – P. 1234-1242.

    94. Field M. G., Harbour J. W. Recent developments in prognostic and predictive testing in uveal melanoma //Current opinion in ophthalmology. – 2014. –Vol. 25. – №. 3. – P. 234.

    95. Finger P. T., Chin K. J., Tena L. B. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve //Ophthalmology. – 2012. – Vol. 119. – №. 2. – P. 415-422.

    96. Finn A. P., Materin M. A., Mruthyunjaya P. Choroidal tumor biopsy: a review of the current state and a glance into future techniques //Retina. – 2018. – Vol. 38. – P. S79-S87.

    97. Folberg R. et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma //Ophthalmology. – 1993. – Vol. 100. – №. 9. – P. 1389-1398.

    98. Furdova A. et al. Uveal melanoma survival rates after single dose stereotactic radiosurgery //Neoplasma. – 2018. – Vol. 65. – №. 6. – P. 965-971.

    99. Furney S. J. et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma //Cancer discovery. – 2013. – Vol. 3. – №. 10. – P. 1122-1129.

    100. Gamel J. W. et al. Uveal melanomas. Correlation of cytologic features with prognosis //Cancer. – 1978. – Vol. 41. – №. 5. – P. 1897-1901.

    101. Ge Y. R. et al. Occupational cooking and risk of uveal melanoma: a metaanalysis //Asian Pac J Cancer Prev. – 2012. – Vol. 13. – №. 10. – С. 4927-4930.

    102. Glasgow B. J. et al. Quantitation of tumor seeding from fine needle aspiration of ocular melanomas //American journal of ophthalmology. – 1988. – Vol. 105. – №. 5. – P. 538-546..

    103. Godfrey D. G., Waldron R. G., Capone Jr A. Transpupillary thermotherapy for small choroidal melanoma //American journal of ophthalmology. – 1999. – Vol. 128. – №. 1. – P. 88-93.

    104. Gokhale R. et al. Diagnostic fine-needle aspiration biopsy for iris melanoma //The Asia-Pacific Journal of Ophthalmology. – 2015. – Vol. 4. – №. 2. – P. 89-91.

    105. Gragoudas E. S. et al. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma //Transactions of the American Ophthalmological Society. – 2002. – Vol. 100. – P. 43.

    106. Gragoudas E. S. Proton beam irradiation of uveal melanomas: the first 30 years the weisenfeld lecture //Investigative ophthalmology & visual science. – 2006. – Vol. 47. – №. 11. – С. 4666-4673.

    107. Griewank K. G. et al. Genetic and clinico-pathologic analysis of metastatic uveal melanoma //Modern pathology. – 2014. – Vol. 27. – №. 2. – С. 175-183.

    108. Guénel P. et al. Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case–control study in France //Cancer Causes & Control. – 2001. – Vol. 12. – №. 5. – P. 451-459.

    109. Gündüz K. et al. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension //American journal of ophthalmology. – 2000. – Vol. 130. – №. 1. – P. 97-102.

    110. Hammer H., Oláh J., Toth-Molnár E. Dysplastic nevi are a risk factor for uveal melanoma //European journal of ophthalmology. – 1996. – Vol. 6. – №. 4. – С. 472-474.

    111. Harbour J. W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas //Science. – 2010. – Vol. 330. – №. 6009. – P. 1410-1413.

    112. Harbour J. W. et al. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma //Nature genetics. – 2013. – Vol. 45. – №. 2. – P. 133-135.

    113. Harbour J. W. A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile //Molecular Diagnostics for Melanoma. – Humana Press, Totowa, NJ, 2014. – P. 427-440.

    114. Häusler T. et al. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3 //International journal of cancer. – 2005. – Vol. 116. – №. 6. – P. 909-913..

    115. Holly E. A. et al. Intraocular melanoma linked to occupations and chemical exposures //Epidemiology. – 1996. – P. 55-61.

    116. Jakobiec F. A. et al. Ultrasonically guided needle biopsy and cytologic diagnosis of solid intraocular tumors //Ophthalmology. – 1979. – Vol. 86. – №. 9. – P. 1662-1678.

    117. Jensen O. A., Andersen S. R. Late complications of biopsy in intraocular tumors //Acta ophthalmologica. – 1959. – Vol. 37. – №. 5. – P. 568-575.

    118. Jochems A. et al. Metastatic uveal melanoma: Treatment strategies and survival–results from the dutch melanoma treatment registry //Cancers. – 2019. – Vol. 11. – №. 7. – P. 1007..

    119. Johansson P. et al. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4 //Oncotarget. – 2016. – Vol. 7. – №. 4. – С. 4624.

    120. Journee-de Korver J. G. et al. Histopathological findings in human choroidal melanomas after transpupillary thermotherapy //British journal of ophthalmology. – 1997. – Vol. 81. – №. 3. – P. 234-239.

    121. Joye R. P. et al. Local Control and Results of Leksell Gamma Knife Therapy for the Treatment of Uveal Melanoma // Ophthalmic Surgery, Lasers and Imaging Retina. 2014. - Vol. 45 – №.2. – P. 125–131.

    122. Kaliki S., Shields C. L. Uveal melanoma: relatively rare but deadly cancer //Eye. – 2017. – Vol. 31. – №. 2. – P. 241-257.

    123. Kaliki S., Shields C. L., Shields J. A. Uveal melanoma: estimating prognosis //Indian journal of ophthalmology. – 2015. – Vol. 63. – №. 2. – P. 93.

    124. Kalirai H. et al. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing //British journal of cancer. – 2014. – Vol. 111. – №. 7. – P. 1373-1380.

    125. Karcioglu Z. A., Gordon R. A., Karcioglu G. L. Tumor seeding in ocular fine needle aspiration biopsy //Ophthalmology. – 1985. – Vol. 92. – №. 12. – P. 1763-1767.

    126. Kilic E. et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients //Investigative ophthalmology & visual science. – 2005. – Vol. 46. – №. 7. – С. 2253-2257.

    127. Kilic E. et al. Clinical and cytogenetic analyses in uveal melanoma //Investigative ophthalmology & visual science. – 2006. – Vol. 47. – №. 9. – P. 3703-3707.

    128. Kim R. S. et al. Histopathologic analysis of transvitreal fine needle aspiration biopsy needle tracts for uveal melanoma //American Journal of Ophthalmology. – 2017. – Vol. 174. – P. 9-16.

    129. Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death // British Journal of Ophthalmology. 2009. – Vol. 93. – №. 9. – P.1129–1131.

    130. Kivelä T., Puusaari I., Damato B. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case–control study //Ophthalmology. – 2003. – Vol. 110. – №. 11. – P. 2235-2244.

    131. Konstantinidis L. et al. Long-term outcome of primary endoresection of choroidal melanoma //British Journal of Ophthalmology. – 2014. – Vol. 98. – №. 1. – P. 82-85.

    132. Konstantinidis L. et al. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy //British Journal of Ophthalmology. – 2014. – Vol. 98. – №. 6. – P. 775-779.

    133. Koopmans A. E. et al. Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11 //British journal of cancer. – 2013. – Vol. 109. – №. 2. – P. 493-496.

    134. Koopmans A. E. et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma //Modern pathology. – 2014. – Vol. 27. – №. 10. – P. 1321-1330.

    135. Li W., Gragoudas E. S., Egan K. M. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma //Archives of Ophthalmology. – 2000. – Vol. 118. – №. 8. – P. 1066-1070.

    136. Lommatzsch P. K. et al. Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106 Ru/106 Rh plaques //Graefe's archive for clinical and experimental ophthalmology. – 1994. – Vol. 232. – №. 8. – P. 482-487.

    137. Lommatzsch P. K., Werschnik C., Schuster E. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma //Graefe's archive for clinical and experimental ophthalmology. – 2000. – Vol. 238. – №. 2. – P. 129-137.

    138. Dogrusöz M., Jager M. J., Damato B. Uveal melanoma treatment and prognostication //The Asia-Pacific Journal of Ophthalmology. – 2017. – Vol. 6. – №. 2. – P. 186-196.

    139. Mäkitie T. et al. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas //Journal of the National Cancer Institute. – 1999. – Vol. 91. – №. 4. – P. 359-367.

    140. Manschot W. A., Peperzeel H. A. Van Uveal melanoma: Location, size, cell type, and enucleation as risk factors in metastasis // Human pathology. – 1982. – Vol. 13. – №. 2. – P. 1147–1148.

    141. Margo C. E. The collaborative ocular melanoma study: an overview //Cancer Control. – 2004. – Vol. 11. – №. 5. – P. 304-309.

    142. Martin M. et al. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3 //Nature genetics. – 2013. – Vol. 45. – №. 8. – P. 933-936.

    143. Mashayekhi A. et al. Extraocular extension of ciliochoroidal melanoma after transscleral fine-needle aspiration biopsy //Retinal Cases and Brief Reports. – 2016. – Vol. 10. – №. 3. – P. 289-292.

    144. McCannel T. A., Chang M. Y., Burgess B. L. Multi-year follow-up of fineneedle aspiration biopsy in choroidal melanoma //Ophthalmology. – 2012. – Vol. 119. – №. 3. – P. 606-610.

    145. McKenzie J. T., Mierzwa M. L. Regarding Stereotactic Radiosurgery for Uveal Melanoma //Jama Ophthalmology. – 2014. – Vol. 132. – №. 3. – С. 367-368.

    146. McLean I. W. et al. Choroidal–Ciliary Body Melanoma: A Multivariate Survival Analysis of Tumor Location //Ophthalmology. – 1995. – Vol. 102. – №. 7. – P. 1060-1064.

    147. Metz C. H. D. et al. Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma //Cancer medicine. – 2013. – Vol. 2. – №. 2. – P. 208-215.

    148. Onken M. D. et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma //Ophthalmology. – 2012. – Vol. 119. – №. 8. – P. 1596-1603.

    149. Melia M. et al. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3 //Archives of ophthalmology (Chicago, Ill.: 1960). – 2006. – Vol. 124. – №. 2. – P. 226.

    150. Moore A. R. et al. Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma //Nature genetics. – 2016. – Vol. 48. – №. 6. – P. 675-680.

    151. Nagiel A. et al. Vitrectomy-assisted biopsy for molecular prognostication of choroidal melanoma 2 mm or less in thickness with a 27-gauge cutter //Retina. – 2017. – Vol. 37. – №. 7. – P. 1377-1382.

    152. Nathan P. et al. Uveal melanoma UK national guidelines //European journal of cancer. – 2015. – Vol. 51. – №. 16. – P. 2404-2412.

    153. Nayman T. et al. Uveal melanoma risk factors: a systematic review of metaanalyses //Current eye research. – 2017. – Vol. 42. – №. 8. – P. 1085-1093.

    154. van de Nes J. A. P. et al. Comparing the prognostic value of BAP1 mutation pattern, chromosome 3 status, and BAP1 immunohistochemistry in uveal melanoma //The American journal of surgical pathology. – 2016. – Vol. 40. – №. 6. – P. 796-805.

    155. Nielsen K. et al. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival //Modern Pathology. – 2014. – Vol. 27. – №. 12. – P. 1641-1648.

    156. Onken M. D. et al. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death //Cancer research. – 2004. – Vol. 64. – №. 20. – P. 7205-7209.

    157. Onken M. D., Worley L. A., Harbour J. W. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis //Clinical Cancer Research. – 2008. – Vol. 14. – №. 12. – P. 3737-3745.

    158. Oosterhuis J. A., Journée-de Korver H. G., Keunen J. E. E. Transpupillary thermotherapy: results in 50 patients with choroidal melanoma //Archives of Ophthalmology. – 1998. – Vol. 116. – №. 2. – P. 157-162.

    159. Park S. J. et al. Nationwide incidence of ocular melanoma in South Korea by using the National cancer registry database (1999–2011) //Investigative ophthalmology & visual science. – 2015. – Vol. 56. – №. 8. – P. 4719-4724.

    160. Parrella P., Sidransky D., Merbs S. L. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway //Cancer Research. – 1999. – Vol. 59. – №. 13. – P. 3032-3037.

    161. Patrone S. et al. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma //Genes, Chromosomes and Cancer. – 2018. – Vol. 57. – №. 8. – P. 387-400.

    162. Paul E. V., Parnell B. L., Fraker M. Prognosis of malignant melanomas of the choroid and ciliary body //International Ophthalmology Clinics. – 1962. – Vol. 2. – №. 2. – P. 387-402.

    163. Pe'er J. Ruthenium-106 brachytherapy //Current Concepts in Uveal Melanoma. – Karger Publishers, 2012. – Vol. 49. – P. 27-40.

    164. Peyman G. A., Apple D. J. Local excision of choroidal malignant melanoma: Full-thickness eye wall resection //Archives of Ophthalmology. – 1974. – Vol. 92. – №. 3. – P. 216-218.

    165. Polyzos S. A., Anastasilakis A. D. A systematic review of cases reporting needle tract seeding following thyroid fine needle biopsy //World journal of surgery. – 2010. – Vol. 34. – №. 4. – P. 844-851..

    166. Potter P De. et al. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival //British journal of ophthalmology. – 1994. – Vol. 78. – №. 2. – P. 109-114..

    167. Qiu M., Shields C. L. Choroidal nevus in the United States adult population: racial disparities and associated factors in the National Health and Nutrition Examination Survey //Ophthalmology. – 2015. – Vol. 122. – №. 10. – P. 2071-2083.

    168. Qiu M., Shields C. L. Relationship between female reproductive factors and choroidal nevus in US women: analysis of data from the 2005-2008 National Health and Nutrition Examination Survey //JAMA ophthalmology. – 2015. – Vol. 133. – №. 11. – P. 1287-1294.

    169. Raamsdonk C. D. Van et al. Mutations in GNA11 in uveal melanoma //New England Journal of Medicine. – 2010. – Vol. 363. – №. 23. – P. 2191-2199.

    170. Robertson A. G. et al. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma //Cancer cell. – 2017. – Vol. 32. – №. 2. – P. 204-220. e15.

    171. Rodrigues M. et al. Association of partial chromosome 3 deletion in uveal melanomas with metastasis-free survival //JAMA ophthalmology. – 2020. – Vol. 138. – №. 2. – P. 182-188.

    172. Royer-Bertrand B. et al. Comprehensive genetic landscape of uveal melanoma by whole-genome sequencing //The American Journal of Human Genetics. – 2016. – Vol. 99. – №. 5. – P. 1190-1198..

    173. Sagoo M. S. et al. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutiv e cases //JAMA ophthalmology. – 2014. – Vol. 132. – №. 6. – P. 697-702.

    174. Sanders T. E., Smith M. E. Biopsy of intraocular tumors: a reevaluation //International ophthalmology clinics. – 1972. – Vol. 12. – №. 1. – P. 163-176.

    175. Sarubi H. C. et al. Molecular and immunohistochemical analyses of uveal melanoma patient cohort //Melanoma research. – 2019. – Vol. 29. – №. 3. – P. 248-253.

    176. Schefler A. C. et al. Extraocular extension of uveal melanoma after fineneedle aspiration, vitrectomy, and open biopsy //JAMA ophthalmology. – 2013. – Vol. 131. – №. 9. – P. 1220-1224.

    177. Schmittel A. et al. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma //European journal of cancer. – 2004. – Vol. 40. – №. 16. – P. 2389-2395.

    178. Scholes A. G. M. et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival //Investigative ophthalmology & visual science. – 2003. – Vol. 44. – №. 3. – P. 1008-1011.

    179. Seddon J. M. et al. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma //Archives of ophthalmology. – 1983. – Vol. 101. – №. 12. – P. 1894-1899.

    180. Seddon J. M. et al. Death from uveal melanoma: number of epithelioid cells and inverse SD of nucleolar area as prognostic factors //Archives of ophthalmology. – 1987. – Vol. 105. – №. 6. – P. 801-806.

    181. Seider M. I. et al. Multi-center analysis of intraocular biopsy technique and outcomes for uveal melanoma: Ocular Oncology Study Consortium report 4 //Graefe's Archive for Clinical and Experimental Ophthalmology. – 2020. – Vol. 258. – №. 2. – P. 427-435.

    182. Sellam A. et al. Fine needle aspiration biopsy in uveal melanoma: technique, complications, and outcomes //American Journal of Ophthalmology. – 2016. – Vol. 162. – P. 28-34. e1.

    183. Sen J. et al. Transretinal choroidal tumor biopsy with a 25-gauge vitrector //Ophthalmology. – 2006. – Vol. 113. – №. 6. – P. 1028-1031.

    184. Seregard S., Kock E. Prognostic indicators following enucleation for posterior uveal melanoma: A multivariate analysis of long-term survival with minimized loss to follow-up //Acta ophthalmologica Scandinavica. – 1995. – Vol. 73. – №. 4. – P. 340-344.

    185. Shah A. A., Bourne T. D., Murali R. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma //Pathology. – 2013. – Vol. 45. – №. 7. – P. 651-656.

    186. Shah C. P. et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis //Ophthalmology. – 2005. – Vol. 112. – №. 9. – P. 1599-1607.

    187. Shields C. L. et al. Survey of 520 eyes with uveal metastases //Ophthalmology. – 1997. – Vol. 104. – №. 8. – С. 1265-1276.

    188. Shields C. L. et al. Combination of clinical factors predictive of growth of small choroidal melanocytic tumors //Archives of Ophthalmology. – 2000. – Vol. 118. – №. 3. – С. 360-364.

    189. Shields C. L. et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations //Ophthalmology. – 2002. – Vol. 109. – №. 2. – С. 225-234.

    190. Shields C. L. et al. Chromosome 3 analysis of uveal melanoma using fineneedle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship //Archives of Ophthalmology. – 2007. – Vol. 125. – №. 8. – P. 1017-1024.

    191. Shields C. L. et al. Small choroidal melanoma with chromosome 3 monosomy on fine-needle aspiration biopsy //Ophthalmology. – 2007. – Vol. 114. – №. 10. – P. 1919-1924.

    192. Shields C. L. et al. Combined hamartoma of the retina and retinal pigment epithelium in 77 consecutive patients: visual outcome based on macular versus extramacular tumor location //Ophthalmology. – 2008. – Vol. 115. – №. 12. – P. 2246-2252. e3.

    193. Shields C. L. et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes //Archives of Ophthalmology. – 2009. – Vol. 127. – №. 8. – P. 989-998.

    194. Shields C. L. et al. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens //Ophthalmology. – 2011. – Vol. 118. – №. 2. – P. 396-401.

    195. Shields C. L. et al. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes //Ophthalmology. – 2013. – Vol. 120. – №. 1. – P. 55-61.

    196. Shields C. L. et al. Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide //Ophthalmology. – 2013. – Vol. 120. – №. 4. – P. 766-772.

    197. Shields C. L. et al. Uveal melanoma in children and teenagers //Saudi Journal of Ophthalmology. – 2013. – Vol. 27. – №. 3. – P. 197-201.

    198. Shields C. L. et al. Personalized prognosis of uveal melanoma based on cytogenetic profile in 1059 patients over an 8-year period: the 2017 Harry S. Gradle Lecture //Ophthalmology. – 2017. – Vol. 124. – №. 10. – P. 1523-1531.

    199. Shields J. A. et al. Partial lamellar sclerouvectomy for ciliary body and choroidal tumors //Ophthalmology. – 1991. – Vol. 98. – №. 6. – P. 971-983.

    200. Shields J. A. et al. Fine-needle aspiration biopsy of suspected intraocular tumors: the 1992 Urwick lecture //Ophthalmology. – 1993. – Vol. 100. – №. 11. – P. 1677-1684.

    201. Shields J. A., Shields C. L., Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1 //Ophthalmology. – 2004. – Vol. 111. – №. 5. – P. 997-1008.

    202. Shields J. A., Zimmerman L. E. Lesions simulating malignant melanoma of the posterior uvea //Archives of ophthalmology. – 1973. – Vol. 89. – №. 6. – P. 466-471.

    203. Shoushtari A. N., Carvajal R. D. GNAQ and GNA11 mutations in uveal melanoma //Melanoma research. – 2014. – Vol. 24. – №. 6. – P. 525-534.

    204. Sieburth R. M., Qiu M., Shields C. L. Sex differences in the relationship between obesity and choroidal nevus in US adults //Investigative ophthalmology & visual science. – 2015. – Vol. 56. – №. 12. – P. 7489-7495.

    205. Singh N. et al. Uveal melanoma: epidemiologic aspects //Clinical Ophthalmic Oncology. – Springer, Berlin, Heidelberg, 2014. – P. 75-87.

    206. Singh A. D. et al. Primary transpupillary thermotherapy of “small” choroidal melanoma: is it safe?. – 2008.

    207. Singh A. D. et al. History, indications, techniques and limitations //FNA Cytology of Ophthalmic Tumors. – Karger Publishers, 2012. – Vol. 21. – P. 1-9.

    208. Singh A. D. et al. Congenital uveal melanoma? //Survey of Ophthalmology. – 2016. – Vol. 61. – №. 1. – P. 59-64.

    209. Singh A. D. et al. Fine-needle aspiration biopsy of uveal melanoma: outcomes and complications //British Journal of Ophthalmology. – 2016. – Vol. 100. – №. 4. – P. 456-462.

    210. Singh A. D. et al. Twenty-five-gauge cannula–assisted fine-needle aspiration biopsy of choroidal melanoma: cytopathological analysis //Retina. – 2017. – Vol. 37. – №. 9. – P. 1674-1677.

    211. Singh A. D., Biscotti C. V. Fine needle aspiration biopsy of ophthalmic tumors //Saudi Journal of Ophthalmology. – 2012. – Vol. 26. – №. 2. – С. 117-123.

    212. Singh A. D., Topham A. Incidence of uveal melanoma in the United States: 1973–1997 //Ophthalmology. – 2003. – Vol. 110. – №. 5. – P. 956-961.

    213. Singh A. D., Turell M. E., Topham A. K. Uveal melanoma: trends in incidence, treatment, and survival //Ophthalmology. – 2011. – Vol. 118. – №. 9. – P. 1881-1885.

    214. Singh N. et al. Uveal melanoma: epidemiologic aspects //Clinical Ophthalmic Oncology. – Springer, Berlin, Heidelberg, 2014. – P. 75-87.

    215. Sisley K. et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis //Genes, Chromosomes and Cancer. – 1997. – Vol. 19. – №. 1. – P. 22-28.

    216. Smith S. J., Smith B. D. Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review //British Journal of Ophthalmology. – 2013. – Vol. 97. – №. 10. – P. 1231-1236.

    217. Suesskind D., Paulsen F. Regarding Stereotactic Radiosurgery for Uveal Melanoma–Reply //Jama Ophthalmology. – 2014. – Vol 132. – №. 3. – P. 368-368.

    218. Szalai E. et al. Uveal melanoma nuclear BRCA1-associated protein-1 immunoreactivity is an indicator of metastasis //Ophthalmology. – 2018. – Vol 125. – №. 2. – P. 203-209.

    219. Thomas S. et al. Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study //British Journal of Cancer. – 2012. – Vol 106. – №. 6. – P. 1171-1176.

    220. Traine P. G. et al. Biopsy with the new essen biopsy forceps //Case Reports in Ophthalmological Medicine. – 2013. – P. 2013.

    221. Vajdic C. M. et al. Incidence of ocular melanoma in Australia from 1990 to 1998 //International journal of cancer. – 2003. – Vol 105. – №. 1. – P. 117-122.

    222. Vaquero-Garcia J. et al. PRiMeUM: a model for predicting risk of metastasis in uveal melanoma //Investigative ophthalmology & visual science. – 2017. – Vol. 58. – №. 10. – P. 4096-4105.

    223. Vidoris A. A. C. et al. Outcomes of primary endoresection for choroidal melanoma //International journal of retina and vitreous. – 2017. – Vol. 3. – №. 1. – P. 1-6.

    224. Virgili G. et al. Incidence of uveal melanoma in Europe //Ophthalmology. – 2007. – Vol. 114. – №. 12. – P. 2309-2315. e2.

    225. Walter S. D. et al. Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma //JAMA ophthalmology. – 2016. – Vol. 134. – №. 7. – P. 734-740.

    226. Whelchel J. C. et al. Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma //Investigative ophthalmology & visual science. – 1993. – Vol. 34. – №. 8. – P. 2603-2606.

    227. Wickremasinghe S. et al. Ocular presentations of breast cancer //Acta Ophthalmologica Scandinavica. – 2007. – Vol. 85. – №. 2. – P. 133-142.

    228. Y Yavuzyigitoglu S. et al. Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases //Ophthalmology. – 2016. – Vol. 123. – №. 5. – P. 1118-1128.

    229. Yazici G. et al. Stereotactic radiosurgery and fractionated stereotactic radiation therapy for the treatment of uveal melanoma //International Journal of Radiation Oncology* Biology* Physics. – 2017. – Vol. 98. – №. 1. – P. 152-158.

    230. Young L. H., Gragoudas E. S. Macular uveal melanoma treated with proton beam irradiation. 10-year follow-up observation with histopathologic correlation //Retina (Philadelphia, Pa.). – 1994. – Vol. 14. – №. 1. – P. 43-46.

    231. Young T. A. et al. Transscleral fine-needle aspiration biopsy of macular choroidal melanoma //American journal of ophthalmology. – 2008. – Vol. 145. – №. 2. – P. 297-302. e1.

    232. Ziemssen F. et al. Analysis of neovasculature in uveal melanoma by targeting the TGFβ-binding receptor endoglin: is there prognostic relevance of proliferating endothelium? //Graefe's Archive for Clinical and Experimental Ophthalmology. – 2006. – Vol. 244. – №. 9. – P. 1124-1131.